# Scott Nolan

> Scott Nolan is a seed investor at General Matter (San Francisco) backing Software and Medical. See 38 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [General Matter](https://shizune.co/investors/profile/general-matter)
- Location: San Francisco, United States
- Total investments: 38
- Last investment: Jun 2026
- Lead investor: 37%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/scottpnolan/
- X (Twitter): http://twitter.com/scottnolan
- Website: https://x.com/scottnolan

Scott Nolan is a seed investor at General Matter in San Francisco focused on Software and Medical. Partner at Founders Fund.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $620k–$17M |
| Series A | $4M–$45M |
| Series B | $32M–$150M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 5 | 13% |
| Medical | 3 | 8% |
| Health Care | 3 | 8% |
| Energy | 2 | 5% |
| Nuclear | 2 | 5% |

62 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 26% |
| Series A | 6 | 16% |
| Series B | 6 | 16% |
| Series D | 3 | 8% |
| Series C | 2 | 5% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 16 | 42% |
| New Zealand | 2 | 5% |
| Brazil | 1 | 3% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Impulse Space | Impulse Space develops spacecraft and propulsion systems that provide transportation and mobility services for payloads operating in space. The company focuses on moving, deploying, and hosting payloads across a range of orbital destinations, including low Earth orbit, geostationary orbit, and other deep-space trajectories. Its vehicle portfolioincludes Mira, a spacecraft designed for payload hosting, deployment, and orbital maneuvers, and Helios, a transfer vehicle intended to transport larger payloads between orbits. Impulse Space designs, manufactures, and tests much of its hardware in-house, covering spacecraft systems, propulsion components, and mission integration. The company supports commercial, civil, and government missions by providing in-space transportation and logistics capabilities after launch. | $500M | Series D | Jun 02, 2026 |  |
| Freeform | Freeform is a 3D printing company offering metal 3D printing solutions for manufacturing companies. Freeform deploys software-defined, self-sufficient metal 3D printing factories around the world, bringing software scalability to physical production. Freeform's technology stack combines advanced sensing, real-time controls, and data-drivenlearning to produce digitally-verified, flawless parts at previously unheard-of speeds and costs. | $67M | Series B | Jan 07, 2026 |  |
| Radiant | Radiant is a technology company that develops portable nuclear microreactors designed to generate electricity and heat in a compact, factory-built form. The company’s flagship product, Kaleidos, is engineered to be transportable to customer sites and to replace traditional power sources such as diesel generators for applications including backuppower and continuous energy supply. Radiant manages design, assembly, fueling, and testing of its reactors with a focus on modular deployment and energy generation without on-site water requirements. It also undertakes infrastructure planning for reactor production facilities to support broader availability of its microreactors. Radiant engages with regulatory processes and industry partners to advance testing and commercialization of its nuclear energy solutions. | $300M | Series D | Dec 17, 2025 |  |
| Network Bio | Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools. | $17M | Seed | Feb 27, 2025 |  |
| Radiant | Radiant is a technology company that develops portable nuclear microreactors designed to generate electricity and heat in a compact, factory-built form. The company’s flagship product, Kaleidos, is engineered to be transportable to customer sites and to replace traditional power sources such as diesel generators for applications including backuppower and continuous energy supply. Radiant manages design, assembly, fueling, and testing of its reactors with a focus on modular deployment and energy generation without on-site water requirements. It also undertakes infrastructure planning for reactor production facilities to support broader availability of its microreactors. Radiant engages with regulatory processes and industry partners to advance testing and commercialization of its nuclear energy solutions. | $165M | Series C | Nov 14, 2024 |  |
| Impulse Space | Impulse Space develops spacecraft and propulsion systems that provide transportation and mobility services for payloads operating in space. The company focuses on moving, deploying, and hosting payloads across a range of orbital destinations, including low Earth orbit, geostationary orbit, and other deep-space trajectories. Its vehicle portfolioincludes Mira, a spacecraft designed for payload hosting, deployment, and orbital maneuvers, and Helios, a transfer vehicle intended to transport larger payloads between orbits. Impulse Space designs, manufactures, and tests much of its hardware in-house, covering spacecraft systems, propulsion components, and mission integration. The company supports commercial, civil, and government missions by providing in-space transportation and logistics capabilities after launch. | $150M | Series B | Oct 01, 2024 |  |
| 9amHealth | 9amHealth is a virtual healthcare company focused on managing chronic cardiometabolic conditions such as diabetes, obesity, high blood pressure, and high cholesterol. The platform connects patients with licensed healthcare providers, pharmacists, nutritionists, prescription delivery services, and at-home laboratory testing through a digital caremodel. Its services include personalized treatment plans, medication management, ongoing monitoring, and remote consultations designed to support long-term condition management. The company also works with employers, health plans, and pharmacy benefit managers to provide healthcare support programs for individuals living with chronic illnesses. 9am.health’s care approach combines medical treatment, behavioral support, and digital tools to help patients access healthcare services remotely and manage their conditions more consistently. | $9.5M | Series A | Feb 19, 2024 |  |
| Impulse Space | Impulse Space develops spacecraft and propulsion systems that provide transportation and mobility services for payloads operating in space. The company focuses on moving, deploying, and hosting payloads across a range of orbital destinations, including low Earth orbit, geostationary orbit, and other deep-space trajectories. Its vehicle portfolioincludes Mira, a spacecraft designed for payload hosting, deployment, and orbital maneuvers, and Helios, a transfer vehicle intended to transport larger payloads between orbits. Impulse Space designs, manufactures, and tests much of its hardware in-house, covering spacecraft systems, propulsion components, and mission integration. The company supports commercial, civil, and government missions by providing in-space transportation and logistics capabilities after launch. | $45M | Series A | Jul 24, 2023 |  |
| Siren Biotechnology | Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transformshow tumor cells are eliminated and anti-tumor immunity is stimulated. |  | Seed | May 17, 2023 |  |
| Radiant | Radiant is a technology company that develops portable nuclear microreactors designed to generate electricity and heat in a compact, factory-built form. The company’s flagship product, Kaleidos, is engineered to be transportable to customer sites and to replace traditional power sources such as diesel generators for applications including backuppower and continuous energy supply. Radiant manages design, assembly, fueling, and testing of its reactors with a focus on modular deployment and energy generation without on-site water requirements. It also undertakes infrastructure planning for reactor production facilities to support broader availability of its microreactors. Radiant engages with regulatory processes and industry partners to advance testing and commercialization of its nuclear energy solutions. | $40M | Series B | Apr 18, 2023 |  |

10 of 38 investments shown.

## Co-investors
- [Eniac Ventures](https://shizune.co/investors/profile/eniac-ventures) — VC Fund, 5 deals together
- [Lux Capital](https://shizune.co/investors/profile/lux-capital) — VC Fund, 5 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 5 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 4 deals together
- [Maverick Ventures](https://shizune.co/investors/profile/maverick-ventures) — VC Fund, 4 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 3 deals together

## About General Matter

VC Fund · California, United States

General Matter is a nuclear energy company that restores nuclear power and produce enriched uranium.

1 contacts available at General Matter.

| Name | Title | Profile |
| --- | --- | --- |
| Scott Nolan | Co-Founder and CEO | https://shizune.co/investors/profile/scott-nolan |

## Similar investors

### Similar industry
- [Reach Capital](https://shizune.co/investors/profile/reach-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [GSV Ventures](https://shizune.co/investors/profile/gsv-acceleration) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Icehouse Ventures](https://shizune.co/investors/profile/icehouse-ventures) — VC Fund
- [Enterprise Angels](https://shizune.co/investors/profile/enterprise-angels) — VC Fund
- [K1W1](https://shizune.co/investors/profile/k1w1) — VC Fund

## Featured in investor lists
- [Transportation Angel Investors in New Zealand](https://shizune.co/investors/transportation-angel-investors-new-zealand)
- [EdTech Investors in New Zealand](https://shizune.co/investors/edtech-investors-new-zealand)
- [EdTech Angel Investors in New Zealand](https://shizune.co/investors/edtech-angel-investors-new-zealand)
- [SaaS Angel Investors in New Zealand](https://shizune.co/investors/saas-angel-investors-new-zealand)
- [All Angel Investors in New Zealand](https://shizune.co/investors/angel-investors-new-zealand)
- [Software Angel Investors in New Zealand](https://shizune.co/investors/software-angel-investors-new-zealand)

## FAQ

### What does Scott Nolan invest in?

Scott Nolan invests primarily in Software, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 38 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Scott Nolan's check size?

Scott Nolan typically joins rounds of $620k–$17M at Seed, $4M–$45M at Series A and $32M–$150M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Scott Nolan participates in.

### When did Scott Nolan last invest?

The most recent investment recorded for Scott Nolan closed in Jun 2026. Shizune tracks 38 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co